Trademark: NEUVIPDA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for NEUVIPDA
We do not have any records of a proof of use for NEUVIPDA at this moment.
Possible trademark infringements of NEUVIPDA
Basic Information about NEUVIPDA
- Serial Number
- 98268772
- Filing Date
- 14 Nov 2023
- Registration Number
- 7534907
- Registration Date
- 15 Oct 2024
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of NEUVIPDA on the blockchain with WikiTrademarks.io.
- First use of NEUVIPDA anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns NEUVIPDA?
1. GlaxoSmithKline Biologicals SA Rixensart
2. GlaxoSmithKline Biologicals SA Rixensart
3. GlaxoSmithKline Biologicals SA Rixensart
Correspondent
- Christopher M. Hanes GSK
- 410 Blackwell Street
- Legal Brand Protection
- Durham, NC 27701
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io